Clinical Trials Browser

Phase 2 × Completed × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all

NCT01492582 2021-10-27

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

Phase 2 Completed

1,499 enrolled 11 charts

Cancer Survivor